All Type of News
Revanex and Zydenar awarded for New Drug Development Prize.
The Korean Drug Research Association nominated Revanex of Yuhan and Zydenar of Dong-A as the 7th Korea New Drug Development Award in the general meeting on Feb. 23.
[First APA new drug: Revanex]
Revanex develop...
Yuhan agreed exclusive distribution of a hemorrhoid therapy.
Yuhan made an exclusive distribution agreement with Japanese Mitsubishi Pharma on Feb. 22 for an exclusive distribution of "Jion", a novel sclerosis therapy for an internal hemorrhoid.
The therapy is directly to in...
KRPIA to discuss drug policy development plans with KFDA.The KRPIA, a foreign multinational drug corporation's group, invited Chief Commissioner of KFDA, Moon Chang-jin on Feb. 22 to hear and discuss the KFDA's 2006 drug policy in att...
|
New KPTA head voted to Mr. Sohn Kyung-tae.Mr. Sohn Kyung-tae was elected the 12th president of the Korea Pharmaceutical Traders Association (KPTA) in the 50th KPTA general congress on Feb. 23.
Mr. Song took a majorit...
|
Multinational drug corporations's drug import on the rise.
The KFDA statistics reported 4 years of drug import from 2002 to 2005 that the total 650 drugs were imported and GSK's Hepcera ranked the top place while number of drug import registrations by foreign multinational dr...
170 million won of incentive plan for the third birth of baby.
A private company announced to provide 170 million won of incentive plans for the promotion of 3rd baby delivery payable until the graduation of college, implying a national critical issue on the low birth rate.
T...
Boehringer Ingelheim Korea to celebrate 30 years anniversary.
Boehring Ingelheim Korea where was highly praised as one of the best model management cases contributed to the Korean people's health and economy will celebrate its 30 year anniversary on March 8.
In the anniversa...
GSK to resume Avandia-Avandamet supply in early March.
GSK will supply two diabetic drugs, Avandia and Avandamet again from the early of March, which had not been smoothly supplied.
GSK said on Feb. 20 that the product supply delay was due to the adoption of new shipp...
Recent price slash critically to damage eye drug makers.
The recent government drug price cut on 1,477 products will seriously batter the drug makers for eye drugs and foreign multinational drug corporations.
Alcon Korea, an eye drug specialized foreign company in Korea,...
'First Brand Grand Prix' for Ketotop, arthritis pain killer.Ketotop, a topical pain killer patch produced and sold by Pacific Pharm. has been selected for "First Brand Grand Prix" in the area of the adhesive arthritis therapy by the Kore...
|
